For Biopharma Partners
E.V.A. (Ex-Vivo Avatar)
E.V.A. is a technology platform that we have developed to combine scaffold-free organoid culture system and AI image analysis to rapidly expand CTCs into heterogeneous cancer-derived organoids for many applications in cancer research, such as cell therapy, cancer vaccine and new drug development.